Genetic landscape of gallbladder cancer: Global overview

Duffy, 2008, Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer centre (MSKCC), J. Surg. Oncol., 98, 485, 10.1002/jso.21141 Arroyo, 2016, Gallbladder cancer: South American experience, Chin. Clin. Oncol., 5, 67, 10.21037/cco.2016.10.01 Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer, 136, E359, 10.1002/ijc.29210 Lazcano-Ponce, 2001, Epidemiology and molecular pathology of gallbladder cancer, CA Cancer J. Clin., 51, 349, 10.3322/canjclin.51.6.349 Torre, 2017, Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers, Clin. Gastroenterol. Hepatol., 16, 427, 10.1016/j.cgh.2017.08.017 Dhir, 1999, Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas, Indian J. Gastroenterol., 18, 24 Mhatre, 2016, Place of birth and risk of gallbladder cancer in India, Indian J. Cancer, 53, 304, 10.4103/0019-509X.197723 Wi, 2018, Trends in gallbladder cancer incidence and survival in Korea, Cancer Res. Treat., 10.4143/crt.2017.279 Liebe, 2015, Modifiable factors and genetic predisposition associated with gallbladder Cancer. A concise review, J. Gastrointestin. Liver Dis., 24, 339, 10.15403/jgld.2014.1121.243.lib Andrea, 2016, Cholesterol gallstones larger than 3 cm appear to be associated with gallbladder cancer: identification of a high risk group of patients that could benefit from preventive cholecystectomy, Ann. Surg., 263, e56, 10.1097/SLA.0000000000001082 Jaruvongvanich, 2017, The incidence rates and survival of gallbladder cancer in the USA, Eur. J. Cancer Prev., 10.1097/CEJ.0000000000000402 Srivastava, 2012, Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy, PLoS One, 7, e40162, 10.1371/journal.pone.0040162 Meyer, 2010, Androgen receptor CAG repeat length and risk of biliary tract cancer and stones, Cancer Epidemiol. Biomarkers Prev., 19, 787, 10.1158/1055-9965.EPI-09-0973 Kang, 2008, FAS -1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer, Cancer Genet. Cytogenet., 180, 1, 10.1016/j.cancergencyto.2007.09.002 Rai, 2014, Death receptor (DR4) haplotypes are associated with increased susceptibility of gallbladder carcinoma in north Indian population, PLoS One, 9, e90264, 10.1371/journal.pone.0090264 Srivastava, 2010, Caspase-8 polymorphisms and risk of gallbladder cancer in a northern Indian population, Mol. Carcinog., 49, 684 Kimura, 2008, Effect of genetic predisposition on the risk of gallbladder cancer in Hungary, Asian Pac. J. Cancer Prev., 9, 391 Tsuchiya, 2010, Evidence that genetic variants of metabolic detoxication and cell cycle control are not related to gallbladder cancer risk in Chilean women, Int. J. Biol. Markers, 25, 75, 10.1177/172460081002500203 Tsuchiya, 2007, Polymorphisms of cytochrome P450 1A1, glutathione S-transferase class mu, and tumour protein p53 genes and the risk of developing gallbladder cancer in Japanese, Clin. Biochem., 40, 881, 10.1016/j.clinbiochem.2007.04.005 Sakai, 2016, CYP1A1, GSTM1, GSTT1 and TP53 polymorphisms and risk of gallbladder cancer in Bolivians, Asian Pac. J. Cancer Prev., 17, 781, 10.7314/APJCP.2016.17.2.781 Pandey, 2006, Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in North India, Biomarkers, 11, 250, 10.1080/13547500600648697 Xu, 2011, Cholesterol metabolism gene polymorphisms and the risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China, Carcinogenesis, 32, 58, 10.1093/carcin/bgq194 Baez, 2010, Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women, World J. Gastroenterol., 16, 372, 10.3748/wjg.v16.i3.372 Sharma, 2013, Association of liver X receptors (LXRs) genetic variants to gallbladder cancer susceptibility, Tumour Biol., 34, 3959, 10.1007/s13277-013-0984-8 Srivastava, 2010, CYP7A1 (-204 A>C; rs3808607 and -469 T>C; rs3824260) promoter polymorphisms and risk of gallbladder cancer in North Indian population, Metabolism, 59, 767, 10.1016/j.metabol.2009.09.021 Gong, 2013, Roles of ApoB-100 gene polymorphisms and the risks of gallstones and gallbladder cancer: a meta-analysis, PLoS One, 8, e61456, 10.1371/journal.pone.0061456 Rai, 2014, CYP17 polymorphism (rs743572) is associated with increased risk of gallbladder cancer in tobacco users, Tumour Biol., 35, 6531, 10.1007/s13277-014-1876-2 Hou, 2006, CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China, Int. J. Cancer, 118, 2847, 10.1002/ijc.21708 Park, 2009, Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China, Carcinogenesis, 30, 606, 10.1093/carcin/bgp024 Wistuba, 2004, Gallbladder cancer: lessons from a rare tumour, Nat. Rev. Cancer, 4, 695, 10.1038/nrc1429 Srivastava, 2009, Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population, J. Gastroenterol., 44, 774, 10.1007/s00535-009-0071-5 Sakoda, 2006, Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China, Carcinogenesis, 27, 1251, 10.1093/carcin/bgi314 Hsing, 2008, Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China, Cancer Res., 68, 6442, 10.1158/0008-5472.CAN-08-0444 Vishnoi, 2008, IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population, Cancer Genet. Cytogenet., 186, 63, 10.1016/j.cancergencyto.2008.05.004 Vishnoi, 2007, Do TNFA -308 G/A and IL6-174 G/C gene polymorphisms modulate risk of gallbladder cancer in the north Indian population?, Asian Pac. J. Cancer Prev., 8, 567 Vishnoi, 2008, Genetic susceptibility of epidermal growth factor +61A&G and transforming growth factor beta1-509C&T gene polymorphisms with gallbladder cancer, Hum. Immunol., 69, 360, 10.1016/j.humimm.2008.04.004 Srivastava, 2008, CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility, Scand. J. Immunol., 67, 516, 10.1111/j.1365-3083.2008.02097.x Srivastava, 2009, Complement receptor 1 (A3650G RsaI and intron 27 HindIII) polymorphisms and risk of gallbladder cancer in north Indian population, Scand. J. Immunol., 70, 614, 10.1111/j.1365-3083.2009.02329.x Srivastava, 2010, Significant association between toll-like receptor gene polymorphisms and gallbladder cancer, Liver Int., 30, 1067, 10.1111/j.1478-3231.2010.02268.x Sharma, 2012, Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer, Liver Int., 32, 1278, 10.1111/j.1478-3231.2012.02822.x Srivastava, 2010, Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India, Cancer, 116, 3160, 10.1002/cncr.25063 Srivastava, 2009, Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population, Ann. Surg. Oncol., 16, 1695, 10.1245/s10434-009-0354-3 Huang, 2008, Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China, Carcinogenesis, 29, 100, 10.1093/carcin/bgm247 Zhang, 2008, Variants of DNA repair genes and the risk of biliary tract cancers and stones: a population-based study in China, Cancer Epidemiol. Biomarkers Prev., 17, 2123, 10.1158/1055-9965.EPI-07-2735 Jiao, 2011, Ala499Val (C&T) and Lys939Gln (A&C) polymorphisms of the XPC gene: their correlation with the risk of primary gallbladder adenocarcinoma–a case-control study in China, Carcinogenesis, 32, 496, 10.1093/carcin/bgq250 Jiao, 2015, Variants and haplotypes in Flap endonuclease 1 and risk of gallbladder cancer and gallstones: a population-based study in China, Sci. Rep., 5, 18160, 10.1038/srep18160 Dixit, 2017, Comparative analysis of mutational profile of sonic hedgehog gene in gallbladder cancer, Dig. Dis. Sci., 62, 708, 10.1007/s10620-016-4438-1 Sharma, 2013, Association of potentially functional genetic variants of PLCE1 with gallbladder cancer susceptibility in north Indian population, J. Gastrointest. Cancer, 44, 436, 10.1007/s12029-013-9537-z Ono, 2013, Missense allele of a single nucleotide polymorphism rs2294008 attenuated antitumor effects of prostate stem cell antigen in gallbladder cancer cells, J. Carcinog., 12, 4, 10.4103/1477-3163.109030 Rai, 2013, PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females, Gene, 530, 172, 10.1016/j.gene.2013.08.058 Kazmi, 2016, A let-7 microRNA binding site polymorphism in the KRAS 3’UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population, J. Cancer Res. Clin. Oncol., 142, 2577, 10.1007/s00432-016-2254-9 Pramanik, 2011, A novel polymorphism in codon 25 of the KRAS gene associated with gallbladder carcinoma patients of the eastern part of India, Genet. Test. Mol. Biomarkers, 15, 431, 10.1089/gtmb.2010.0194 Rai, 2014, Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population, J. Cancer Res. Clin. Oncol., 140, 725, 10.1007/s00432-014-1621-7 Li, 2014, Vitamin D receptor genetic variants are associated with susceptibility of gallbladder adenocarcinoma in a Chinese cohort, Genet. Mol. Res., 13, 5387, 10.4238/2014.July.24.18 Srivastava, 2011, Gallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes, PLoS One, 6, e16449, 10.1371/journal.pone.0016449 Sharma, 2014, A multigenic approach to evaluate genetic variants of PLCE1, LXRs, MMPs, TIMP, and CYP genes in gallbladder cancer predisposition, Tumour Biol., 35, 8597, 10.1007/s13277-014-2094-7 Rai, 2015, A multiple interaction analysis reveals ADRB3 as a potential candidate for gallbladder cancer predisposition via a complex interaction with other candidate gene variations, Int. J. Mol. Sci., 16, 28038, 10.3390/ijms161226077 Yadav, 2016, Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival, Tumour Biol., 37, 8083, 10.1007/s13277-015-4728-9 Yadav, 2016, Association of cancer stem cell markers genetic variants with gallbladder cancer susceptibility, prognosis, and survival, Tumour Biol., 37, 1835, 10.1007/s13277-015-3929-6 Gupta, 2015, Evaluation of miR-27a, miR-181a, and miR-570 genetic variants with gallbladder cancer susceptibility and treatment outcome in a North Indian population, Mol. Diagn. Ther., 19, 317, 10.1007/s40291-015-0159-y Srivastava, 2010, Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population, J. Hum. Genet., 55, 495, 10.1038/jhg.2010.54 Cha, 2012, A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population, J. Hum. Genet., 57, 235, 10.1038/jhg.2012.9 Mhatre, 2017, Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study, Lancet Oncol., 18, 535, 10.1016/S1470-2045(17)30167-5 Rai, 2013, DCC (deleted in colorectal carcinoma) gene variants confer increased susceptibility to gallbladder cancer (Ref. No.: Gene-D-12-01446), Gene, 518, 303, 10.1016/j.gene.2013.01.019 Tebbi, 2016, Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress, Carcinogenesis, 37, 39, 10.1093/carcin/bgv156 Miyahara, 2014, Interaction of Muc4 and ErbB2 in a transgenic mouse model of gallbladder carcinoma: potential pathobiological implications, Oncol. Rep., 32, 1796, 10.3892/or.2014.3443 Li, 2017, TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT, Oncotarget, 8, 47052, 10.18632/oncotarget.16789 Huang, 2016, Rescued expression of WIF-1 in gallbladder cancer inhibits tumor growth and induces tumor cell apoptosis with altered expression of proteins, Mol. Med. Rep., 14, 2573, 10.3892/mmr.2016.5532 Weber, 2017, Small molecule inhibitor screening identified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer, Oncotarget, 8, 26169, 10.18632/oncotarget.15410 Li, 2017, Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing, Oncotarget, 8, 36319, 10.18632/oncotarget.16751 Meacham, 2013, Tumour heterogeneity and cancer cell plasticity, Nature, 501, 328, 10.1038/nature12624 Kleppe, 2014, Tumor heterogeneity confounds and illuminates: assessing the implications, Nat. Med., 20, 342, 10.1038/nm.3522 Parsons, 2017, Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas, Environ. Mol. Mutagen., 58, 466, 10.1002/em.22110 Alexandrov, 2015, Clock-like mutational processes in human somatic cells, Nat. Genet., 47, 1402, 10.1038/ng.3441 Sharma, 2014, Association of genetic variants of xenobiotic and estrogen metabolism pathway (CYP1A1 and CYP1B1) with gallbladder cancer susceptibility, Tumour Biol., 35, 5431, 10.1007/s13277-014-1708-4 Srivastava, 2011, Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis, Mutat. Res., 728, 67, 10.1016/j.mrrev.2011.06.002 Ajiki, 1996, K-ras gene mutation in gall bladder carcinomas and dysplasia, Gut, 38, 426, 10.1136/gut.38.3.426 Roa, 2004, K-ras gene mutation in gallbladder carcinoma, Rev. Med. Chil., 132, 955 Roa, 2005, Frequency of K-ras mutation in biliary and pancreatic tumors, Rev. Med. Chil., 133, 1434 Singh, 2004, Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer, J. Gastroenterol. Hepatol., 19, 916, 10.1111/j.1440-1746.2004.03355.x Tada, 1990, Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing, Cancer, 66, 930, 10.1002/1097-0142(19900901)66:5<930::AID-CNCR2820660519>3.0.CO;2-W Masuhara, 2000, Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction, J. Hepatobiliary. Surg., 7, 198, 10.1007/s005340050176 Hanada, 1996, K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct, Cancer, 77, 452, 10.1002/(SICI)1097-0142(19960201)77:3<452::AID-CNCR5>3.0.CO;2-M Hanada, 1999, Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct, Am. J. Gastroenterol., 94, 1638, 10.1111/j.1572-0241.1999.01155.x Ueki, 2004, Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China, Clin. Cancer Res., 10, 1717, 10.1158/1078-0432.CCR-1137-3 Tang, 2004, Mitochondrial DNA mutation at the D310 (displacement loop) mononucleotide sequence in the pathogenesis of gallbladder carcinoma, Clin. Cancer Res., 10, 1041, 10.1158/1078-0432.CCR-0701-3 Fujii, 1996, High frequency of p53 gene mutation in adenocarcinomas of the gallbladder, Cancer Epidemiol. Biomarkers Prev., 5, 461 Deshpande, 2011, Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma, BMC Cancer, 11, 60, 10.1186/1471-2407-11-60 Jiao, 2013, Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas, Nat. Genet., 45, 1470, 10.1038/ng.2813 Kumari, 2014, Mutation profiling in gallbladder cancer in Indian population, Indian J. Pathol. Microbiol., 57, 9, 10.4103/0377-4929.130849 Li, 2014, Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway, Nat. Genet., 46, 872, 10.1038/ng.3030 Javle, 2014, Molecular characterization of gallbladder cancer using somatic mutation profiling, Hum. Pathol., 45, 701, 10.1016/j.humpath.2013.11.001 Nakamura, 2015, Genomic spectra of biliary tract cancer, Nat. Genet., 47, 1003, 10.1038/ng.3375 Javle, 2016, Biliary cancer: utility of next-generation sequencing for clinical management, Cancer, 122, 3838, 10.1002/cncr.30254 Simbolo, 2014, Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups, Oncotarget, 5, 2839, 10.18632/oncotarget.1943 Noguchi, 2017, Genetic alterations in Japanese extrahepatic biliary tract cancer, Oncol. Lett., 14, 877, 10.3892/ol.2017.6224 Yadav, 2017, Targeted gene sequencing of gallbladder carcinoma identifies high-impact somatic and rare germline mutations, Cancer Genomics Proteomics, 14, 495 Wardell, 2018, Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations, J. Hepatol., 68, 959, 10.1016/j.jhep.2018.01.009 Neyaz, 2018, Investigation of targetable predictive and prognostic markers in gallbladder carcinoma, J. Gastrointest. Oncol., 9, 111, 10.21037/jgo.2017.10.02